Research Initiative/Treatment Action! - ABACAVIR
March 1, 2000 -- Abacavir tablets are yellow, capsule-shaped, film-coated and imprinted with "GX623" on one side. The drug is also available in an oral...
Business Wire - Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA® in Europe
December 11, 2007 -- PRINCETON, N.J. & FOSTER CITY, Calif. -- Bristol-Myers Squibb Company (NYSE:BMY) and Gilead Sciences, Inc. (Nasdaq:GILD) today announced an...
Business Wire - European CHMP Issues Positive Opinion for ATRIPLA
October 18, 2007 -- -- Once Granted by the European Commission, ATRIPLA Would Represent the First And Only Once-Daily Single Tablet Regimen for Many HIV/AIDS Patients in...
Business Wire - Health Canada Approves ATRIPLA® , the First Once-Daily Single Tablet Regimen for HIV
October 17, 2007 -- Product Developed Through Joint Venture Between Bristol-Myers Squibb Company and Gilead Sciences, the First of Its Kind in HIV Treatment PRINCETON,...
Drug Store News - Aurobindo Pharma's
June 26, 2006 -- Aurobindo Pharma's generic abacavir sulfate tablets have received tentative approval from the FDA. These are the first generic version of Ziagent...
M2 Presswire - FDA gives tentative approval to new generic AIDS drug in association with the President's Emergency Plan for AIDS Relief.
May 18, 2006 -- M2 PRESSWIRE-18 May 2006-US FDA: FDA gives tentative approval to new generic AIDS drug in association with the President's Emergency Plan for AIDS...
Internal Medicine News - Combination HIV-1 drug approved
October 1, 2004 -- Epzicom (abacavir/lamivudine) is approved for the treatment of HIV-1 infection. The formulation is a fixed-dose combination of the antiretroviral...
Medical Marketing and Media - GSK, FDA probe HIV-drug tampering
July 1, 2002 -- The FDA is investigating reports that four bottles of GlaxoSmithKline's (GSK's) Combivir (lamivudine plus zidovudine) 60 tablets were found to...
Nursing - Two separate tampering alerts issued
August 1, 2002 -- ZYPREXA, ZIAGEN Eli Lilly has notified health care professionals of product tampering with the medication Zyprexa (olanzapine), which is indicated...
Chemical Market Reporter - Glaxosmithkline Plc. (Active Pharmaceutical Ingredient Watch).(Counterfeit labels for Combivir tablets were placed on two bottles of Ziagen)(Brief Article)
May 20, 2002 -- GLAXOSMITHKLINE PLC (GSK) has received four reports of suspect bottles containing 60 tablets of Combivir (lamivudine plus zidovudine) that actually...
